Maryam Keshvari

699 total citations
45 papers, 523 citations indexed

About

Maryam Keshvari is a scholar working on Hepatology, Epidemiology and Genetics. According to data from OpenAlex, Maryam Keshvari has authored 45 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hepatology, 38 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Maryam Keshvari's work include Hepatitis C virus research (42 papers), Hepatitis B Virus Studies (38 papers) and Liver Disease Diagnosis and Treatment (30 papers). Maryam Keshvari is often cited by papers focused on Hepatitis C virus research (42 papers), Hepatitis B Virus Studies (38 papers) and Liver Disease Diagnosis and Treatment (30 papers). Maryam Keshvari collaborates with scholars based in Iran, Netherlands and Iraq. Maryam Keshvari's co-authors include Seyed Moayed Alavian, Bita Behnava, Heidar Sharafi, Seyyed Mohammad Miri, Kamran Bagheri Lankarani, Seyed Vahid Tabatabaei, Hossein Keyvani, Ali Kabir, Ali Akbari Sari and Abbas Kebriaeezadeh and has published in prestigious journals such as PLoS ONE, Transfusion and Liver International.

In The Last Decade

Maryam Keshvari

45 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Keshvari Iran 14 439 416 29 28 26 45 523
Bita Behnava Iran 15 568 1.3× 533 1.3× 37 1.3× 34 1.2× 37 1.4× 57 644
Vanessa Haynes–Williams United States 8 448 1.0× 448 1.1× 54 1.9× 28 1.0× 17 0.7× 9 561
Heidar Sharafi Iran 17 605 1.4× 622 1.5× 59 2.0× 23 0.8× 29 1.1× 89 818
Montserrat Maldonado‐González Mexico 11 305 0.7× 332 0.8× 37 1.3× 19 0.7× 28 1.1× 26 432
Stefano De Virgilis Italy 5 318 0.7× 309 0.7× 30 1.0× 13 0.5× 33 1.3× 8 398
Angie Price United States 8 394 0.9× 341 0.8× 39 1.3× 12 0.4× 16 0.6× 13 498
Laurentius Lesmana Indonesia 7 409 0.9× 487 1.2× 39 1.3× 20 0.7× 10 0.4× 11 578
J.-P. Zarski France 8 650 1.5× 586 1.4× 18 0.6× 22 0.8× 149 5.7× 14 719
Isabelle Portal France 15 633 1.4× 645 1.6× 22 0.8× 9 0.3× 25 1.0× 28 763
Carmen Monica Preda Romania 12 231 0.5× 297 0.7× 22 0.8× 37 1.3× 12 0.5× 52 445

Countries citing papers authored by Maryam Keshvari

Since Specialization
Citations

This map shows the geographic impact of Maryam Keshvari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Keshvari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Keshvari more than expected).

Fields of papers citing papers by Maryam Keshvari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Keshvari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Keshvari. The network helps show where Maryam Keshvari may publish in the future.

Co-authorship network of co-authors of Maryam Keshvari

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Keshvari. A scholar is included among the top collaborators of Maryam Keshvari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Keshvari. Maryam Keshvari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sharafi, Heidar, et al.. (2017). A Simple PCR-RFLP Method for Genotyping ofIFNL4rs368234815 Polymorphism in Patients With Chronic Hepatitis C. Laboratory Medicine. 48(1). 51–56. 9 indexed citations
3.
Keshvari, Maryam, et al.. (2016). Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran. PLoS ONE. 11(9). e0162492–e0162492. 3 indexed citations
4.
Keshavarz, Khosro, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.. (2016). A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model. Hepatitis Monthly. 16(9). e37435–e37435. 10 indexed citations
5.
Alavian, Seyed Moayed, et al.. (2015). High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study. Pediatric Hematology and Oncology. 32(6). 399–405. 4 indexed citations
6.
Sali, Shahnaz, et al.. (2015). Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?. Diagnostic Microbiology and Infectious Disease. 82(2). 114–119. 6 indexed citations
7.
Keshvari, Maryam, et al.. (2015). Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfusion and Apheresis Science. 53(1). 38–47. 16 indexed citations
8.
Keshavarz, Khosro, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.. (2015). Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran. Hepatitis Monthly. 15(4). e25854–e25854. 35 indexed citations
9.
Keshvari, Maryam, Seyed Moayed Alavian, & Heidar Sharafi. (2015). Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur Journal of Microbiology. 8(3). e21444–e21444. 11 indexed citations
10.
Keshvari, Maryam, et al.. (2014). Interferon Alpha-2b Therapy in Chronic Hepatitis Delta. Hepatitis Monthly. 14(3). e15729–e15729. 5 indexed citations
11.
Keshvari, Maryam, Seyed Moayed Alavian, & Heidar Sharafi. (2014). How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?. Hepatitis Monthly. 14(1). e15285–e15285. 6 indexed citations
12.
Sharafi, Heidar, et al.. (2014). The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study. Hepatitis Monthly. 14(10). e22649–e22649. 23 indexed citations
13.
Keshvari, Maryam & Heidar Sharafi. (2014). Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered. Hepatitis Monthly. 14(4). e19433–e19433. 3 indexed citations
14.
Abbasinazari, Mohammad, Bita Behnava, Yunes Panahi, et al.. (2013). lasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?. Hepatitis Monthly. 13(8). e11138–e11138. 8 indexed citations
15.
Sharafi, Heidar, et al.. (2012). Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepatitis Monthly. 12(12). e8387–e8387. 30 indexed citations
16.
Alavian, Seyed Moayed, Seyyed Mohammad Miri, Seyed Vahid Tabatabaei, et al.. (2011). Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients. Gut and Liver. 5(3). 348–355. 12 indexed citations
17.
Alavian, Seyed Moayed, Seyed Vahid Tabatabaei, Maryam Keshvari, et al.. (2010). Peginterferon α-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases. Liver International. 30(8). 1173–1180. 39 indexed citations
18.
Keshvari, Maryam, Seyed Moayed Alavian, Bita Behnava, et al.. (2010). Distribution of hepatitis C virus genotypes in Iranian patients with congenital bleeding disorders.. Iranian Red Crescent Medical Journal. 12(6). 608–614. 20 indexed citations
19.
Alavian, Seyed Moayed, et al.. (2008). Frequency of Fatty Liver and Some of Its Risk Factors in Asymptomatic Carriers of HBV Attending the Tehran Blood Transfusion Organization Hepatitis Clinic. Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān./Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān.. 10(238). 99–106. 5 indexed citations
20.
Kabir, Ali, et al.. (2007). EFFECT OF VACCINATION AGAINST HEPATITIS B IN CASES WITH ISOLATED ANTI-HBC. 12(2). 86–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bita Behnava Breakdown of academic impact, for papers by Vanessa Haynes–Williams Breakdown of academic impact, for papers by Heidar Sharafi Breakdown of academic impact, for papers by Montserrat Maldonado‐González Breakdown of academic impact, for papers by Stefano De Virgilis Breakdown of academic impact, for papers by Angie Price Breakdown of academic impact, for papers by Laurentius Lesmana Breakdown of academic impact, for papers by J.-P. Zarski Breakdown of academic impact, for papers by Isabelle Portal Breakdown of academic impact, for papers by Carmen Monica Preda
Rankless by CCL
2026